Augmented Therapeutic Potential of Glutaminase Inhibitor CB839 in Glioblastoma Stem Cells Using Gold Nanoparticle Delivery

• Autors principals: Beatriz Giesen (Autor), Ann-Christin Nickel (Autor), Juri Barthel (Autor), Ulf Dietrich Kahlert (Autor), Christoph Janiak (Autor)
• Format: Llibre
• Publicat: MDPI AG, 2021-02-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Gold nanoparticles (Au NPs) are studied as delivery systems to enhance the effect of the glutaminase1 inhibitor CB839, a promising drug candidate already in clinical trials for tumor treatments. Au NPs were synthesized using a bottom-up approach and covered with polymers able to bind CB839 as a Au-p...